Internationale Pressestelle

Elsevier is a global leader in advanced information and decision support for science and healthcare. For more than 140 years, we’ve helped advance science and healthcare to advance human progress, and that same mission drives us today. We are part of RELX Wird in neuem Tab/Fenster geöffnet, a FTSE 10 company and global provider of information-based analytics and decision tools for professional and business customers.

The communities we serve across academia, R&D driven industries and healthcare are working to solve some of the world’s biggest challenges -- we strive to bring them the best solutions and to be the best partner possible for progress. We deliver insights that help research institutions, governments and funders achieve their goals. We help researchers discover and share knowledge, collaborate, and accelerate innovation. We help librarians provide verified, quality information to universities. We help innovators turn knowledge into new medicines and products. We help health professionals improve patient care and educators train the next generation of doctors and nurses.

Our trusted brands include the world’s leading research platforms like ScienceDirect and Scopus, technical databases such as Reaxys for chemicals, best-in-class clinical tools like ClinicalKey and innovative learning platforms such as Sherpath and Osmosis for nursing — all enriched by responsible AI.

Last year, our 3,000+ scientific journals received 3.5 million research papers and published 720K articles after rigorous editorial and peer review, reflecting our focus on quality. This is also reflected in the fact that the research published by Elsevier accounts for 17% of global research articles and 29% of global citations.